EMA Authorised: Rukobia (fostemsavir trometamol) — ViiV Healthcare B.V.

View source ↗

Summary

The European Medicines Agency authorised Rukobia (fostemsavir trometamol) for HIV infections, expanding treatment options for adults with multidrug-resistant HI…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Rukobia (fostemsavir)

Snippet

Status: Authorised. Therapeutic area: HIV Infections. MAH: ViiV Healthcare B.V.. Decision date: 08/09/2025